Medical specialists from Canada tagged as investigators in clinical trials studying Esophageal Cancer
Total 26 results
-
Andrew Seely, MD, PhD, FRCSCSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Principal Investigator)
Conditions: -
Arif AwanSeen in:
- Ontario, Ottawa, Ottawa Hospital Cancer Centre
- Ontario, Ottawa, University of Ottawa / Ottawa General Hospital
Trials:- NCT05571839 (Principal Investigator)
- NCT04609566 (Principal Investigator)
- NCT05194072 (Principal Investigator)
- NCT04665921 (Principal Investigator)
- NCT05229900 (Principal Investigator)
Conditions:- Colorectal Neoplasms;
- Pancreatic Neoplasms;
- Mesothelioma;
- Non-small Cell Lung Cancer;
- Cutaneous Melanoma;
- Melanoma;
- Squamous Cell Carcinoma of the Head and Neck;
- Carcinoma, Non-Small-Cell Lung;
- Adenoid Cystic Carcinoma;
- Ovarian Neoplasms;
- Fallopian Tube Neoplasms;
- Peritoneal Neoplasms;
- Endometrial Neoplasms;
- Cholangiocarcinoma;
- Triple Negative Breast Neoplasms;
- Gallbladder Carcinoma;
- HER2 Negative Breast Neoplasms;
- Hormone Receptor Positive Breast Neoplasms;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Esophageal Neoplasms;
- Pseudomyxoma Peritonei;
- Carcinoma, Non-Small Cell Lung;
- Gastroesophageal Junction Carcinoma;
- Exocrine Pancreatic Adenocarcinoma;
- Appendiceal Adenocarcinoma;
- Testicular Neoplasms
-
Christian Finley, MD, FRCPCSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Sub-Investigator)
Conditions: -
Daniel Breadner, MD MScSeen in:
- Ontario, London, London Health Sciences Centre - Victoria Hospital
Trials:- NCT05314946 (Sub-Investigator)
Conditions: -
David Palma, MD PhDSeen in:
- Ontario, London, London Health Sciences Centre - Victoria Hospital
Trials:- NCT05314946 (Sub-Investigator)
Conditions: -
Dean Fergusson, PhDSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Sub-Investigator)
Conditions: -
Dugald Seely, ND, MScSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Principal Investigator)
Conditions: -
Elena Elimova, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Center
- Ontario, Toronto, Princess Margaret Cancer Centre
- Toronto, Princess Margaret Cancer Centre
Trials:- NCT05152147 (Principal Investigator)
- NCT04752358 (Principal Investigator)
- NCT03929666 (Principal Investigator)
-
Ellen Conte, NDSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Sub-Investigator)
Conditions: -
Enrico M Minnella, MD PhDSeen in:
- Quebec, Montreal, McGill University Health Centre
Trials:- NCT04581005 (Principal Investigator)
Conditions: -
Gail Darling, MDSeen in:
- Ontario, Toronto, University Health Network: Toronto General Hospital
Trials:- NCT02495337 (Principal Investigator)
Conditions: -
Kednapa Thavorn, PhDSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Sub-Investigator)
Conditions: -
Marcus Butler, M.D.Seen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT02869217 (Principal Investigator)
- NCT05963217 (Principal Investigator)
- NCT04044859 (Principal Investigator)
Conditions:- Melanoma;
- Esophageal Cancer;
- Ovarian Cancer;
- Lung Cancer;
- Bladder Cancer;
- Liver Cancer;
- Synovial Sarcoma;
- NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients;
- Relapsed or Refractory Chronic Lymphocytic Leukemia;
- Relapsed or Refractory Small Lymphocytic Lymphoma;
- Relapsed or Refractory CD19+ B-cell Lymphoma;
- Head and Neck Cancer;
- Endometrial Cancer;
- Urothelial Cancer;
- Gastric (Stomach) Cancer;
- Esophagogastric Junction (EGJ);
- Non-small Cell Lung (NSCLC)
-
Mehdi Qiabi, MD MScSeen in:
- Ontario, London, London Health Sciences Centre - Victoria Hospital
Trials:- NCT05314946 (Principal Investigator)
Conditions: -
Michael Sanatani, MDSeen in:
- Ontario, London, London Health Sciences Centre - Victoria Hospital
Trials:- NCT05314946 (Sub-Investigator)
Conditions: -
Neesha Dhani, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, University Health Network (Princess Margaret Cancer Center)
- Other, Toronto, University Health Network, Princess Margaret Hospital
Trials:- NCT05601752 (Principal Investigator)
- NCT04665921 (Principal Investigator)
- NCT04084951 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Colorectal Neoplasms;
- Esophageal Neoplasms;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Pseudomyxoma Peritonei;
- Carcinoma, Non-Small Cell Lung;
- Gastroesophageal Junction Carcinoma;
- HER2 Negative Breast Neoplasms;
- Exocrine Pancreatic Adenocarcinoma;
- Appendiceal Adenocarcinoma;
- Adult Solid Tumor
-
Patrick Veit-Haiback, MDSeen in:
- Ontario, Toronto, Univeristy Health Network
Trials:- NCT04560036 (Principal Investigator)
Conditions: -
Philippe L. BedardSeen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:- NCT04317105 (Principal Investigator)
- NCT04491942 (Principal Investigator)
Conditions:- Advanced Malignant Solid Neoplasm;
- Unresectable Malignant Solid Neoplasm;
- Metastatic Malignant Solid Neoplasm;
- Anatomic Stage III Breast Cancer AJCC v8;
- Anatomic Stage IV Breast Cancer AJCC v8;
- Stage III Lung Cancer AJCC v8;
- Stage IV Lung Cancer AJCC v8;
- Clinical Stage III Gastric Cancer AJCC v8;
- Clinical Stage IV Gastric Cancer AJCC v8;
- Triple-Negative Breast Carcinoma;
- Stage IV Penile Cancer AJCC v8;
- Advanced Gastric Carcinoma;
- Advanced Breast Carcinoma;
- Stage III Cervical Cancer AJCC v8;
- Stage IV Cervical Cancer AJCC v8;
- Advanced Lung Non-Small Cell Carcinoma;
- Stage III Ovarian Cancer AJCC v8;
- Stage IV Ovarian Cancer AJCC v8;
- Advanced Ovarian Carcinoma;
- Unresectable Urothelial Carcinoma;
- Advanced Head and Neck Carcinoma;
- Advanced Lung Small Cell Carcinoma;
- Advanced Urothelial Carcinoma;
- Stage IV Distal Bile Duct Cancer AJCC v8;
- Stage IV Intrahepatic Bile Duct Cancer AJCC v8;
- Advanced Esophageal Carcinoma;
- Advanced Endometrial Carcinoma;
- Advanced Pleural Malignant Mesothelioma;
- Stage III Distal Bile Duct Cancer AJCC v8;
- Advanced Bile Duct Carcinoma;
- Advanced Cervical Carcinoma;
- Advanced Penile Carcinoma;
- Stage III Intrahepatic Bile Duct Cancer AJCC v8;
- Stage III Penile Cancer AJCC v8;
- Stage III Pleural Malignant Mesothelioma AJCC v8;
- Stage IV Pleural Malignant Mesothelioma AJCC v8
-
Rahul Nayak, MDSeen in:
- Ontario, London, London Health Sciences Centre - Victoria Hospital
Trials:- NCT05314946 (Sub-Investigator)
Conditions: -
Ramy Saleah, MD MSc FRCPCSeen in:
- Quebec, Montreal, McGill University Health Centre Glen Site
Trials:- NCT04752358 (Principal Investigator)
Conditions: -
Rebecca Auer, MD, FRCSC, FACSSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Sub-Investigator)
Conditions: -
Richard A Malthaner, MD MScSeen in:
- Ontario, London, London Health Sciences Centre - Victoria Hospital
Trials:- NCT05314946 (Sub-Investigator)
Conditions: -
Salmaan Kanji, BSc, PharmDSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Sub-Investigator)
Conditions: -
Tim Asmis, MD, FRCPCSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Sub-Investigator)
Conditions: -
Tim Ramsay, PhDSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT04871412 (Sub-Investigator)
Conditions:
Clinical Trials on Esophageal Cancer
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityWithdrawnStage IIB Esophageal Cancer AJCC v7 | Stage III Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7
-
National Cancer Institute (NCI)NRG OncologyCompletedEsophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IB Esophageal Cancer AJCC v7United States
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedEsophageal Cancer | Gastrooesophageal Cancer | Oesophageal Cancer | GastroEsophageal Cancer | Esophageal Cancers NOS | Oesophageal Cancer Metastatic | Esophageal Cancer Metastatic | Oesophageal Cancer NosGermany
-
University of Wisconsin, MadisonActive, not recruitingResectable Esophageal Cancer | GastroEsophageal CancerUnited States
-
Tianjin Medical University Cancer Institute and...Sun Yat-sen University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsNot yet recruitingStage III Esophageal Cancer | Stage II Esophageal Cancer
-
Tianjin Medical University Cancer Institute and...UnknownStage III Esophageal Cancer | Stage II Esophageal CancerChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7 | Malignant Neoplasm of the Cervical Esophagus | Malignant Neoplasm...United States
-
Cancer Institute and Hospital, Chinese Academy...Tianjin Medical University Cancer Institute and Hospital; Sichuan Cancer Hospital...UnknownEsophageal Neoplasm | Esophageal Cancer TNM Staging Primary Tumor (T) T3 | Esophageal Cancer TNM Staging Primary Tumor (T) T2 | Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0 | Esophageal Cancer TNM Staging Distal Metastasis (M) M0China
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtCompletedEsophageal Cancer, Stage II | Esophageal Cancer Stage IIINetherlands
-
Tianjin Medical University Cancer Institute and...The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsUnknownEsophageal Cancer Stage III | Esophageal Cancer Stage IIBChina